Nimodipine for reducing alcohol drinking
Treatments studied
Part of Mental health clinical trials.
This study tests if a blood-pressure medicine called nimodipine can help people who drink heavily reduce their alcohol intake. The trial involves lab-based drinking sessions and brain scans to understand how the drug works on the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 50 years old.
- You should drink a certain amount each week: 30–70 standard drinks if you are a man, or 20–65 if you are a woman.
- You must have a moderate to severe alcohol use disorder (but not be currently seeking treatment).
- You need to be able to read and understand English at a basic level.
- You should not be pregnant or nursing, and must use reliable birth control if you are able to have children.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the medication nimodipine (usually used for blood pressure) can help people who drink heavily reduce how much they drink. If you join, you may receive the medication or a placebo (a pill with no active ingredient) and take part in drinking sessions to see how it affects you.
This study tests whether a new medication called NTX-2001 can help people with alcohol use disorder drink less. Researchers will measure how the drug affects alcohol consumption and safety in adults aged 21–60.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.
This early-phase study looks at how alcohol affects impulsivity (tendency to act quickly) and people’s subjective experiences. You may be able to join if you drink regularly and meet the study safety rules.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.